Peter G Stock

Title: Innovations by Inventor Peter G. Stock in the Field of Cell Death Pathways

Introduction

Peter G. Stock, an innovative inventor based in San Francisco, CA, has made significant contributions to the field of biotechnology. With a focus on polypeptides that activate the Fas receptor-mediated pathway involved in cell death, his work showcases the intersection of science and therapeutic applications. His patent has the potential to impact treatments for various disorders associated with Fas receptor dysregulation.

Latest Patents

Peter G. Stock holds a notable patent for a "Noncleavable Fas ligand." This invention encompasses polypeptides that include a noncleavable form of a Fas ligand, which is essential for activating the Fas receptor-mediated pathway. Moreover, it outlines pharmaceutical compositions that utilize these polypeptides, nucleic acids encoding them, and cell lines capable of expressing such nucleic acids. The patent additionally provides therapeutic and prophylactic methods for treating patients experiencing disorders linked to the inappropriate stimulation or dysregulation of the Fas receptor-mediated pathway.

Career Highlights

Peter G. Stock is associated with the University of California, where he actively engages in research and development in the biotechnological arena. His dedication to innovation has positioned him as a key figure in his laboratory, contributing valuable insights and advancements in cell death mechanisms and their therapeutic implications.

Collaborations

Throughout his career, Peter has collaborated with esteemed colleagues such as Sang-Mo Kang and Andries Erik Braat. These collaborations reflect a shared commitment to advancing research in biotechnology and improving treatment options for patients facing health challenges.

Conclusion

In summary, Peter G. Stock demonstrates the power of innovation in biotechnology through his patented work on the Noncleavable Fas ligand. By merging scientific research with practical applications, he is paving the way for new therapeutic approaches to managing disorders linked to the Fas receptor-mediated pathway. His contributions at the University of California highlight the vital role inventors play in shaping the future of medicine and healthcare.